Read Article

Supporting international business matching, LSMIP propritizes "Speed" and "Accuracy" in out service.
Please be noted that contents are in English/Japanese, translated on a request basis from authors/members.
国際間のビジネス・マッチングを促進するため、LSMIPでは情報発信の迅速性・正確性を重視しております。
コンテンツは各言語(英語、日本語)でお読みいただけますが、必要に応じて翻訳する場合があります。

Overview

1

Japanese Drug Pricing System and Patient's Access to New Drugs

                                                                                          
  • Target market
    Japan
  • Business category
    Pharmaceutical, Biopharmaceutical, Regerative medicine
  • Business function
    Regulatory >
  • Keyword
  • Author
    "Representative author" of "CM Plus Corporation"
  • Availability
    Membership

Detail

  Japan has a universal health care insurance system, and all the people in Japan are enrolled in public medical insurance. It is a system which allows patients to freely choose hospital and doctor at their own discretion yet receive high-level medical care at a low patient's cost. The drug prices to be reimbursed by medical insurance are determined by the government, and will be revised periodically to control medical expenses after marketed. There are various rules set for this drug price system, as outlined below:

 
(Continued)

Comments (Require approval)

What information are you looking for in articles?
Let us help you to find out the articles for your business requirements!
Like many other companies, we use cookies and other technologies, some of which are essential to make our website work. By clicking Accept or continuing to use our site, you agree to use these cookies and other technologies. To learn more, check out our privacy policy.
Accept